Back

Hypo- and hyperthyroidism in patients with new-onset atrial fibrillation: a nationwide study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Drivers and modifiers of atrial fibrillation Clinical ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Mika Lehto

Helsinki University Hospital, Helsinki (Finland)

8 More presentations in this session

Presentation thumbnail
Discussant - Drivers and modifiers of atrial fibrillation
Presentation thumbnail
Prevalence of sinus node dysfunction in patients with implantable cardiac monitor for cryptogenetic stroke: a manifestation of atrial cardiomyopathy?
Doctor P. Festa (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Association of clonal hematopoesis and autonomic dysfunction with cardiovacular outcomes in atrial fibrillation
Doctor P. Haemmerle (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Osteosarcopenia and risk of atrial fibrillation from the UK Biobank
Assistant Professor K. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Intravenous vagal stimulation catheter induces rapid heart rate reduction without hemodynamic compromise in a dog model of atrial fibrillation with severe tachycardia
Doctor T. Watanabe (Fukuoka, JP)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Drivers and modifiers of atrial fibrillation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion
thumbnail
Congress Presentation
Oral anticoagulation in subclinical atrial fibrillation: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources